Work

Resistance to PARP Inhibitors Mediated by Secondary BRCA1/2 Mutations

Year: 2015

Type: book-chapter

Source: Cancer drug discovery and develogment/Cancer drug discovery and development

DOI: 10.1007/978-3-319-14151-0_18

Authors: Kiranjit K. Dhillon, Toshiyasu Taniguchi

Institutions: Howard Hughes Medical Institute, Fred Hutch Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Clovis Oncology, National Institutes of Health, National Cancer Institute

OpenAlex ID: W2280556735

FWCI: 2.657

Cites: 69

Cited by: 5

Related to: 10